Response to: risk of lung disease with the Pi*SS genotype of alpha-1 antitrypsin: the evidence in context
Saved in:
Main Authors: | Teresa Martín, Marc Miravitlles |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Respiratory Research |
Online Access: | https://doi.org/10.1186/s12931-024-03065-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of lung disease with the Pi*SS genotype of alpha-1 antitrypsin: the evidence in context
by: Helen O’Brien, et al.
Published: (2025-01-01) -
Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project
by: Teresa Martín, et al.
Published: (2024-06-01) -
Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy
by: Atharv V. Oak, MEng, et al.
Published: (2025-02-01) -
High Serum Level of IL-17 in Patients with Chronic Obstructive Pulmonary Disease and the Alpha-1 Antitrypsin PiZ Allele
by: Margarita Y. Pervakova, et al.
Published: (2020-01-01) -
Self-administration of augmentation therapy for alpha 1-antitrypsin deficiency
by: A. Vianello, et al.
Published: (2025-01-01)